Analysts, investors upbeat about Schering-Plough settlement

07/19/2004 | Star-Ledger (Newark, N.J.), The

Several analysts are encouraged by Schering-Plough's likely $350 million settlement with federal investigators over Medicare fraud allegations, saying it will unburden the company from the years-long probe and allow it to move ahead. The settlement comes as Schering-Plough expects to receive FDA approval, possibly this week, of its blockbuster cholesterol drug, Vytorin, which could result in sales of more than $1 billion a year.

View Full Article in:

Star-Ledger (Newark, N.J.), The

Published in Brief:

SmartBrief Job Listings for Food & Beverage

Job Title Company Location
Executive Chef
University of Southern California
Los Angeles, CA
Director - Web Marketing
The Culinary Institute of America
Hyde Park, NY
Director of Food and Beverage Operations
The Culinary Institute of America
San Antonio, TX
Hospitality and Customer Service Instructor
The Culinary Institute of America
San Antonio, TX
Culinarians Wanted, Kitchen Management Training in NYC
Hillstone Restaurant Group
New York City, NY